In mice with low thyroid hormone levels, cefuroxime changes how the brain responds to those low levels, causing the pituitary gland to release less TSH than expected, which may disrupt normal hormone regulation.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review would determine whether D2 inhibition consistently alters TSH feedback dynamics across hypothyroid models and inhibitors.
A systematic review and meta-analysis of all studies measuring serum TSH, TRH, and thyroid hormone levels in hypothyroid rodents after D2 inhibition, comparing cefuroxime to other inhibitors and controls, with standardized assay protocols.
An RCT would determine whether cefuroxime alters TSH suppression dynamics in hypothyroid mice compared to placebo during thyroid hormone replacement.
A double-blind RCT in 80 hypothyroid mice (thyroidectomized), randomized to receive levothyroxine (10 µg/kg/day) with or without cefuroxime (10 mg/kg/day), measuring serum TSH, T4, and T3 at 0, 7, and 14 days to assess feedback sensitivity.
Could assess whether cefuroxime exposure correlates with altered TSH dynamics in hypothyroid mice across multiple labs.
A prospective cohort of 150 hypothyroid mice from 10 institutions, tracking cefuroxime exposure and serial TSH measurements during hormone replacement, adjusting for strain, age, and dose timing.
Could test whether mice with blunted TSH response to T4 replacement are more likely to have received cefuroxime.
A case-control study comparing 40 hypothyroid mice with blunted TSH suppression (<50% reduction after T4) to 80 controls with normal suppression, assessing prior cefuroxime exposure via institutional records.
Could identify whether cefuroxime-exposed hypothyroid mice show different TSH levels than unexposed ones.
A cross-sectional analysis of 120 hypothyroid mice, measuring serum TSH and T4 levels in those exposed to cefuroxime within 72 hours versus those never exposed, adjusting for time since thyroidectomy and hormone dose.